ArticleJournal of hematopathology2026
Oral manifestations of anaplastic large cell lymphoma: clinicopathological features and main immunophenotypic findings of 3 cases.
Article in Journal of hematopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaplastic large cell lymphoma (ALCL) is contained within a larger category of aggressive mature T-cell lymphomas. Their subclassification relies on the presence or absence of Anaplastic Lymphoma Kinase (ALK) gene fusions and other molecular alterations. Cases in the head and neck and mouth are uncommon. The aim of this manuscript is to describe the clinicopathological and immunohistochemical features of a series of anaplastic large cell lymphoma (ALCL) affecting the oral cavity. Three cases are included in this series, all of them affecting male patients, with a mean age of 27.7 years old. Concomitant involvement of the oral cavity and lymph nodes was known to occur in two cases, while cutaneous lesions were not recorded in any patient. The neoplasms more often presented as solitary or multiple painful swellings in the gingiva. All cases were positive for CD30 expression, and the two cases investigated for CD3 were negative. ALK protein was expressed in two cases, and it was negative in one case. EBER was negative in the two cases investigated. One patient was known to decease despite chemotherapy. In conclusion, oral manifestations of ALCL are very rare and more commonly represent a disseminated disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.